• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期脱硫使抗体药物偶联物中组织蛋白酶可裂解连接子的快速高效固相合成成为可能。

Late-Stage Desulfurization Enables Rapid and Efficient Solid-Phase Synthesis of Cathepsin-Cleavable Linkers for Antibody-Drug Conjugates.

机构信息

School of Chemical Sciences, The University of Auckland, 23 Symonds St., Auckland 1010, New Zealand.

Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, 3A Symonds Street, Auckland 1010, New Zealand.

出版信息

Bioconjug Chem. 2024 Jul 17;35(7):1007-1014. doi: 10.1021/acs.bioconjchem.4c00199. Epub 2024 Jun 14.

DOI:10.1021/acs.bioconjchem.4c00199
PMID:38874557
Abstract

The synthesis of linker-payloads is a critical step in developing antibody-drug conjugates (ADCs), a rapidly advancing therapeutic approach in oncology. The conventional method for synthesizing cathepsin B-labile dipeptide linkers, which are commonly used in ADC development, involves the solution-phase assembly of cathepsin B-sensitive dipeptides, followed by the installation of self-immolative -aminobenzyl carbonate to facilitate the attachment of potent cytotoxic payloads. However, this approach is often low yield and laborious, especially when extending the peptide chain with components like glutamic acid to improve mouse serum stability or charged amino acids or poly(ethylene glycol) moieties to enhance linker hydrophilicity. Here, we introduce a novel approach utilizing late-stage desulfurization chemistry, enabling safe, facile, and cost-effective access to the cathepsin B-cleavable linker, Val-Ala-PABC-MMAE, on resin for the first time.

摘要

Linker-payloads 的合成是开发抗体药物偶联物(ADC)的关键步骤,ADC 是肿瘤学领域中一种快速发展的治疗方法。在 ADC 开发中常用的组织蛋白酶 B 不稳定二肽接头的传统合成方法涉及组织蛋白酶 B 敏感二肽的溶液相组装,然后安装自毁性 - 氨基苄基碳酸酯,以方便有效细胞毒性有效载荷的连接。然而,这种方法通常产量低且费力,尤其是在通过谷氨酸等成分扩展肽链以提高小鼠血清稳定性或带电荷的氨基酸或聚(乙二醇)部分以增强接头亲水性时。在这里,我们介绍了一种利用后期脱硫化学的新方法,首次在树脂上实现了安全、简便且具有成本效益的方法,以获得可切割组织蛋白酶 B 的接头 Val-Ala-PABC-MMAE。

相似文献

1
Late-Stage Desulfurization Enables Rapid and Efficient Solid-Phase Synthesis of Cathepsin-Cleavable Linkers for Antibody-Drug Conjugates.晚期脱硫使抗体药物偶联物中组织蛋白酶可裂解连接子的快速高效固相合成成为可能。
Bioconjug Chem. 2024 Jul 17;35(7):1007-1014. doi: 10.1021/acs.bioconjchem.4c00199. Epub 2024 Jun 14.
2
Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers.通过自动固相掺入组织蛋白酶 B 敏感二肽接头工程酶切寡核苷酸。
Angew Chem Int Ed Engl. 2022 Mar 21;61(13):e202114016. doi: 10.1002/anie.202114016. Epub 2022 Feb 10.
3
Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates.组织蛋白酶 B 敏感性触发因子和亲水连接子对新型定点抗体药物偶联物体外疗效的影响。
Org Biomol Chem. 2018 Mar 14;16(11):1882-1889. doi: 10.1039/c7ob02780j.
4
Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers.通过引入新型可裂解二肽连接子优化抗体药物偶联物 (ADC) 的溶酶体激活
Mol Pharm. 2019 Dec 2;16(12):4817-4825. doi: 10.1021/acs.molpharmaceut.9b00696. Epub 2019 Oct 29.
5
Synthesis, characterization, and targeted chemotherapy of SCT200-linker-monomethyl auristatin E conjugates.SCT200-连接子-单甲基澳瑞他汀 E 缀合物的合成、表征及靶向化疗。
Eur J Med Chem. 2021 Apr 15;216:113297. doi: 10.1016/j.ejmech.2021.113297. Epub 2021 Feb 24.
6
Rapid, High-Yielding Solid-Phase Synthesis of Cathepsin-B Cleavable Linkers for Targeted Cancer Therapeutics.用于靶向癌症治疗的组织蛋白酶B可裂解连接子的快速、高产率固相合成
Bioconjug Chem. 2020 Dec 16;31(12):2685-2690. doi: 10.1021/acs.bioconjchem.0c00563. Epub 2020 Dec 4.
7
Effect of attachment site on stability of cleavable antibody drug conjugates.连接位点对可裂解抗体药物偶联物稳定性的影响。
Bioconjug Chem. 2015 Apr 15;26(4):650-9. doi: 10.1021/bc5005747. Epub 2015 Feb 20.
8
Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates.用于抗体药物偶联物的垂饰形聚乙二醇化连接子的优化
J Control Release. 2024 Nov;375:74-89. doi: 10.1016/j.jconrel.2024.08.049. Epub 2024 Sep 5.
9
Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.基于二肽的抗体小沟结合物的设计、合成及体外评价
J Med Chem. 2005 Mar 10;48(5):1344-58. doi: 10.1021/jm040137q.
10
Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers.通过组织蛋白酶B敏感二肽接头的自动固相掺入工程化酶可切割的寡核苷酸。
Angew Chem Weinheim Bergstr Ger. 2022 Mar 21;134(13):e202114016. doi: 10.1002/ange.202114016. Epub 2022 Feb 10.

引用本文的文献

1
A platform for SpyCatcher conjugation to native antibodies.一个用于将SpyCatcher与天然抗体偶联的平台。
Chem Sci. 2025 May 6. doi: 10.1039/d5sc02286j.
2
Understanding the chemistry & pharmacology of antibody-drug conjugates in triple-negative breast cancer with special reference to exatecan derivatives.了解抗体药物偶联物在三阴性乳腺癌中的化学和药理学,特别关注喜树碱衍生物。
Med Oncol. 2024 Oct 26;41(12):301. doi: 10.1007/s12032-024-02542-y.